Stay updated on Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the study record content, removing access to the NCT04345367 trial details and locations. This replaces the prior study information with an error page, affecting how users can view or reference this trial on ClinicalTrials.gov.
    Difference
    18%
    Check dated 2026-09-22T21:49:50.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.6 to v3.7.0, indicating a minor update to the page system or content without changing the study information.
    Difference
    0.0%
    Check dated 2026-09-15T21:46:04.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    A new publication citation for the post hoc analysis of abrocitinib in atopic dermatitis was added to the Publications section, and the previous online-ahead-of-print citation was removed, reflecting a newer version of the paper.
    Difference
    0.0%
    Check dated 2026-09-01T18:02:13.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    An addition appears in the study identifiers: '2019 ( U.S. NIH Grant/Contract )', indicating NIH funding for the U.S. portion of the trial.
    Difference
    0.0%
    Check dated 2026-08-25T16:34:02.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    A new post hoc analysis publication is added to the Publications section, and the previously listed publication entry is removed/updated to reflect its publication status.
    Difference
    0.0%
    Check dated 2026-08-11T08:21:36.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.6.4, replacing the previous v3.6.3. This appears to be a minor revision tag update with no substantive changes to the study content in the provided data.
    Difference
    0.0%
    Check dated 2026-07-28T03:00:13.000Z thumbnail image

Stay in the know with updates to Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.